Ajanta Pharma share price
You have to be logged in to add this to Watchlist.- ₹2,895.85(3.29%)April 13, 2026 15:44:03 PM IST
- NSE
- BSE
- Vol : 161.30 K (NSE + BSE)Last 20 day avg : 135.71 K
Ajanta Pharma is trading 3.29% upper at Rs 2,895.85 as compared to its last closing price. Ajanta Pharma has been trading in the price range of 2,919.00 & 2,772.55. Ajanta Pharma has given 4.64% in this year & 5.65% in the last 5 days. Ajanta Pharma has TTM P/E ratio 34.09 as compared to the sector P/E of 25.29.There are 14 analysts who have initiated coverage on Ajanta Pharma. There are 7 analysts who have given it a strong buy rating & 6 analysts have given it a buy rating. 1 analysts have given the stock a sell rating.The company posted a net profit of 273.77 Crores in its last quarter.Listed peers of Ajanta Pharma include Divi's Laboratories (-1.01%), Dr Reddy's Laboratories (0.24%), Torrent Pharmaceuticals (0.21%).The Mutual Fund holding in Ajanta Pharma was at 15.22% in 31 Mar 2026. The MF holding has decreased from the last quarter. The FII holding in Ajanta Pharma was at 8.26% in 31 Mar 2026. The FII holding has increased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on Apr 14, 2026, 03:40 PM UTC
- BetaLow volatility0.64Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityLower than industry0.01The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldHigher than industry1.93Annual dividends as a percentage of the stock price.
- P/BHigher than historical values9.55The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/EHigher than historical values35.68Price-to-earnings ratio based on trailing 12-month earnings
- PEG RatioIndicates overvaluation3.50The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
|
| ||||
|
| ||||
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Divi's Laboratories | Moderately Bearish | 6,057.50 | -1.01 | 1,61,192.52 | 78.61 | 11.52 | 0.46 | 0.01 |
| Dr Reddy's Laboratories | Bearish | 1,235.00 | 0.24 | 1,03,092.01 | 18.63 | 3.14 | 0.63 | 2.34 |
| Torrent Pharmaceuticals | Bullish | 4,166.00 | 0.21 | 1,41,432.36 | 67.32 | 17.1 | 0.83 | 17.62 |
| Sun Pharmaceutical Industries | Bearish | 1,652.00 | -0.16 | 3,96,360.80 | 36.24 | 5.77 | 0.92 | 0.50 |
| Cipla | Bearish | 1,211.30 | -1.49 | 97,846.71 | 22.95 | 3.87 | 0.87 | 0.81 |
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-01-30 | Quarterly Results |
| 2025-11-03 | Quarterly Results & Interim Dividend |
| 2025-07-28 | Quarterly Results & Others |
| 2025-04-30 | Audited Results & A.G.M. |
| 2025-01-30 | Quarterly Results |
- IndustryBiotechnology & Drugs
- ISININE031B01049
- BSE Code532331
- NSE CodeAJANTPHARM
Ajanta Pharma is trading at 2895.85 as on Mon Apr 13 2026 10:14:03. This is 3.29% upper as compared to its previous closing price of 2803.50.
The market capitalization of Ajanta Pharma is 36179.48 Cr as on Mon Apr 13 2026 10:14:03.
The average broker rating on Ajanta Pharma is Strong Buy. The breakup of analyst rating is given below -
- 7 analysts have given a strong buy rating
- 6 analysts have given a buy rating
- 0.00 analysts have given a hold rating
- 1 analysts have given a sell rating
- 0.00 analysts have given a strong sell rating
The 52 wk high for Ajanta Pharma is 3158.20 whereas the 52 wk low is 2335.00
Ajanta Pharma can be analyzed on the following key metrics -
- TTM P/E: 34.09
- Sector P/E: 25.29
- Dividend Yield: 1.93%
- D/E ratio: -
Ajanta Pharma reported a net profit of 920.39 Cr in 2025.
The Mutual Fund Shareholding was 15.22% at the end of 31 Mar 2026.